Literature DB >> 12735137

A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma.

Annelore Altendorf-Hofmann1, Johannes Scheele.   

Abstract

Hepatic resections for metastatic colorectal cancer have dramatically increased, and there is clear evidence of the effectiveness of this type of surgery. Controversy, however, persists regarding appropriate patient selection, extent and timing of liver resection, and adjuvant or alternative therapeutic options. This article reviews the authors' experience with more than 600 hepatic resections and the relevant literature is discussed. The results underscore the importance of macroscopically and histologically complete tumor clearance, a so-called "R0 resection."

Entities:  

Mesh:

Year:  2003        PMID: 12735137     DOI: 10.1016/s1055-3207(02)00091-1

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  55 in total

Review 1.  Current treatment for colorectal liver metastases.

Authors:  Evangelos P Misiakos; Nikolaos P Karidis; Gregory Kouraklis
Journal:  World J Gastroenterol       Date:  2011-09-28       Impact factor: 5.742

Review 2.  Hepatic resection for colorectal metastases: the impact of surgical margin status on outcome.

Authors:  George A Poultsides; Richard D Schulick; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2010-02       Impact factor: 3.647

3.  Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection.

Authors:  Ryan M Thomas; Mark J Truty; Graciela M Nogueras-Gonzalez; Jason B Fleming; Jean-Nicolas Vauthey; Peter W T Pisters; Jeffrey E Lee; David C Rice; Wayne L Hofstetter; Robert A Wolff; Gauri R Varadhachary; Huamin Wang; Matthew H G Katz
Journal:  J Gastrointest Surg       Date:  2012-05-30       Impact factor: 3.452

4.  Safety analysis of the oncological outcome after vein-preserving surgery for colorectal liver metastases detached from the main hepatic veins.

Authors:  Federico Tomassini; Italo Bonadio; Peter Smeets; Karen De Paepe; Giammauro Berardi; Liesbeth Ferdinande; Stéphanie Laurent; Louis J Libbrecht; Karen Geboes; Roberto I Troisi
Journal:  Langenbecks Arch Surg       Date:  2015-08-12       Impact factor: 3.445

5.  Targeted therapies in colorectal cancer: surgical considerations.

Authors:  Carrie Luu; Amanda K Arrington; Hans F Schoellhammer; Gagandeep Singh; Joseph Kim
Journal:  J Gastrointest Oncol       Date:  2013-09

Review 6.  Treatment for multiple bilobar liver metastases of colorectal cancer.

Authors:  Hiroshi Shimada; Kuniya Tanaka; Kenichi Matsuo; Shinji Togo
Journal:  Langenbecks Arch Surg       Date:  2005-12-01       Impact factor: 3.445

Review 7.  Curable metastatic colorectal cancer: recommended paradigms.

Authors:  Richard N Berri; Eddie K Abdalla
Journal:  Curr Oncol Rep       Date:  2009-05       Impact factor: 5.075

8.  Extended pathology reporting of resection specimens of colorectal liver metastases: the significance of a tumour pseudocapsule.

Authors:  Matthew G Wiggans; Golnaz Shahtahmassebi; Paul Malcolm; Frances McCormick; Somaiah Aroori; Matthew J Bowles; David A Stell
Journal:  HPB (Oxford)       Date:  2012-12-27       Impact factor: 3.647

9.  Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy.

Authors:  Andreas Andreou; Thomas A Aloia; Antoine Brouquet; Paxton V Dickson; Giuseppe Zimmitti; Dipen M Maru; Scott Kopetz; Evelyne M Loyer; Steven A Curley; Eddie K Abdalla; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2013-06       Impact factor: 12.969

10.  Repeat liver resection for recurrent colorectal metastases: a single-centre, 13-year experience.

Authors:  Narendra Battula; Dimitrios Tsapralis; David Mayer; John Isaac; Paolo Muiesan; Robert P Sutcliffe; Simon Bramhall; Darius Mirza; Ravi Marudanayagam
Journal:  HPB (Oxford)       Date:  2013-03-27       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.